DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease
MANUFACTURER: AstraZeneca Pharmaceuticals LP
USAGE: Oral
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Breztri Aerosphere is a pharmaceutical medication that is primarily used for the treatment of chronic obstructive pulmonary disease (COPD). This medication is designed to provide relief and management of the symptoms associated with COPD, which includes chronic bronchitis and emphysema.
